Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Exploding Head Zone -- The Interface of Molecular and Growth-Based Drug Susceptibility Testing

Webinar/Podcast
Exploding Head Zone -- The Interface of Molecular and Growth-Based Drug Susceptibility Testing

This 75-minute webinar provides information on how to put together results from conventional growth-based and molecular methods of TB drug susceptibility testing (including conflicting or contradictory results) to request further testing and/or design optimal treatment regimens for TB patients.

Author:

Curry International Tuberculosis Center

Audiences:

Lab Personnel, Nurses, Physicians

Topic:

Diagnosis, Diagnosis- Laboratory Procedures

Country of Origin:

United States

View Webpage

Related Materials

Landscape and Language of Molecular Diagnostics for TB Drug Resistance

This online course is designed to provide TB control staff, clinicians, and nurses a brief overview of basic principles of molecular technology and test platforms used for molecular testing of Mycobacterium tuberculosis as a basis for understanding how mutations are associated with drug resistance and what reporting language might be used to describe resistance results.

Training

Report of Expert Consultations on Rapid Molecular Testing to Detect Drug-Resistant Tuberculosis in the United States

This report presents results from an expert panel convened by CDC to examine the current status of rapid drug-resistance (DR) testing in the United States; to research published evidence and current guidelines; and to provide guidance and make recommendations to CDC for developing a system to provide access to rapid drug-susceptibility testing to all TB control programs in the United States. The panel recommended that CDC establish regional laboratories to provide molecular drug-resistance testing services to state and local TB programs. A phased approach to developing and implementing the testing service was advised. The panel also strongly recommended that CDC immediately establish a service to provide molecular DR testing for TB suspects and patients at high risk of having MDR TB and those deemed high priority by the state or local TB program. The report discusses the background on tests for molecular detection of DR, general considerations and principles for a molecular DR testing service, possible scenarios and scope of testing for such a service, research needs, general recommendations, a communication plan for the report recommendations, and a list of panel members and CDC participants. The appendices include a molecular basis of DR and molecular DR tests, roles and responsibilities in a regional laboratory system for providing for molecular DR testing for TB, and a flow chart of steps in a molecular DR testing service.

Report

Treatment of Drug-Susceptible Culture Confirmed Tuberculosis for Adults

This poster displays first-line TB treatment regimens, dosing recommendations and frequency, and adverse reactions and monitoring. The poster is 17×22 inches.

Poster

Global resources for the prevention,
management, and elimination of TB.